Irenic Capital Management LP Has $67 Million Stake in Sotera Health Company $SHC

Irenic Capital Management LP lifted its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 7.0% in the 4th quarter, HoldingsChannel reports. The fund owned 3,798,026 shares of the company’s stock after purchasing an additional 249,955 shares during the period. Sotera Health makes up approximately 4.5% of Irenic Capital Management LP’s investment portfolio, making the stock its 2nd biggest holding. Irenic Capital Management LP’s holdings in Sotera Health were worth $66,997,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. IFP Advisors Inc grew its holdings in Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares in the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health during the fourth quarter worth $27,000. True Wealth Design LLC grew its holdings in Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after buying an additional 1,456 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in Sotera Health during the fourth quarter worth $40,000. Finally, Allworth Financial LP grew its holdings in Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock worth $53,000 after buying an additional 2,729 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 15.36% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Barclays decreased their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Finally, Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.29.

Sotera Health Stock Down 3.6%

Shares of NASDAQ:SHC opened at $15.46 on Thursday. The company has a market capitalization of $4.41 billion, a PE ratio of 37.71 and a beta of 1.79. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The business has a fifty day moving average price of $15.67 and a two-hundred day moving average price of $16.35. Sotera Health Company has a 1 year low of $10.84 and a 1 year high of $19.85.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.